Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

Knowledge

  1. Home>
  2. News>
  3. Knowledge>
  4. Page 4

How to Verify WHO-GMP Certification for Indian Generic Medicines: A Buyer’s Guide

  • Post published:September 20, 2026
  • Post category:Knowledge

When you're sourcing generic medicines from India — whether you're a hospital procurement officer, a retail pharmacy, or an international buyer — one of the most important quality markers you…

Continue Reading How to Verify WHO-GMP Certification for Indian Generic Medicines: A Buyer’s Guide

How to Verify Genuine Generic Medicines: A 2026 Buyer’s Safety Checklist

  • Post published:September 18, 2026
  • Post category:Knowledge

Buying generic medicines online or from unfamiliar pharmacies can save you significant money — but it also carries real risks if the product is substandard, falsified, or improperly stored. This…

Continue Reading How to Verify Genuine Generic Medicines: A 2026 Buyer’s Safety Checklist

How to Verify WHO-GMP Certification for Indian Generic Medicines

  • Post published:September 16, 2026
  • Post category:Knowledge

🏬 What Is WHO-GMP and Why Does It Matter? The World Health Organization's Good Manufacturing Practices (WHO-GMP) is an international benchmark for pharmaceutical manufacturing quality. Unlike national GMP standards, WHO-GMP…

Continue Reading How to Verify WHO-GMP Certification for Indian Generic Medicines

Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma

  • Post published:September 13, 2026
  • Post category:Knowledge

The Central Drugs Standard Control Organisation (CDSCO) has been steadily tightening India's drug manufacturing quality standards through the revised Schedule M of the Drugs and Cosmetics Rules. For pharmaceutical manufacturers,…

Continue Reading Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 69
  • Go to the next page

Recent Posts

  • How India Trains Drug Inspectors: WHO Fellowship & GMP Checks
    November 17, 2026/
    0 Comments
  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • How India Trains Drug Inspectors: WHO Fellowship & GMP Checks
  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve